港股荣昌生物（09995.HK）今日盘中大涨5.24%，引发市场关注。消息面上，该公司近期获得国际知名保险和资产管理集团安联（Allianz SE）增持，可能是推动股价上涨的重要因素。
根据港交所最新权益披露资料显示，Allianz SE于2025年4月16日在场内增持荣昌生物257.55万股，平均价格为33.9181港元/股，总投资额约8735.61万港元。此次增持后，Allianz SE持有荣昌生物的股份数量达到1106.05万股，持股比例从4.48%上升至5.83%。
Allianz SE作为全球领先的金融服务提供商，其增持行为往往被视为对公司发展前景的看好。这一举动可能增强了投资者对荣昌生物未来发展的信心，从而推动了股价的上涨。市场人士认为，国际大型机构投资者的参与可能为荣昌生物带来更多的资金支持和国际关注度，有利于公司的长期发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.